Wall Street Zen Downgrades Hyliion (NYSE:HYLN) to Sell

Hyliion (NYSE:HYLN) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday.

A number of other equities analysts also recently commented on the stock. Johnson Rice initiated coverage on shares of Hyliion in a report on Tuesday, October 21st. They issued a “buy” rating and a $5.00 target price for the company. Zacks Research upgraded shares of Hyliion from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 13th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $5.00.

Hyliion Trading Up 5.1%

Shares of Hyliion stock opened at $2.28 on Friday. The stock’s fifty day moving average price is $1.95 and its 200-day moving average price is $1.65. Hyliion has a 12 month low of $1.11 and a 12 month high of $4.09. The firm has a market cap of $400.00 million, a P/E ratio of -6.16 and a beta of 2.51.

Insider Buying and Selling at Hyliion

In other Hyliion news, Director Richard Joseph Freeland purchased 65,000 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were acquired at an average price of $1.57 per share, for a total transaction of $102,050.00. Following the completion of the purchase, the director owned 222,798 shares of the company’s stock, valued at approximately $349,792.86. The trade was a 41.19% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 20.90% of the company’s stock.

Institutional Investors Weigh In On Hyliion

A number of large investors have recently modified their holdings of the business. O ROURKE & COMPANY Inc grew its stake in shares of Hyliion by 50.0% during the third quarter. O ROURKE & COMPANY Inc now owns 20,006 shares of the company’s stock worth $39,000 after acquiring an additional 6,670 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Hyliion by 10.9% during the second quarter. JPMorgan Chase & Co. now owns 76,835 shares of the company’s stock worth $101,000 after acquiring an additional 7,574 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of Hyliion by 15.1% during the first quarter. AQR Capital Management LLC now owns 76,957 shares of the company’s stock worth $108,000 after acquiring an additional 10,076 shares during the last quarter. SG Americas Securities LLC purchased a new stake in shares of Hyliion during the third quarter worth about $27,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in shares of Hyliion during the first quarter worth about $26,000. Hedge funds and other institutional investors own 22.81% of the company’s stock.

Hyliion Company Profile